雅本化学：公司仍在持续向富美实供货中

Core Viewpoint - Yabon's strategic partnership with Heng Rui aims to enhance its innovative pharmaceutical CDMO business competitiveness and expand its business scale, which does not affect its ongoing collaboration with Fumisi [2]. Group 1 - Yabon has signed a strategic cooperation agreement with Heng Rui, focusing on strengthening its CDMO business [2]. - The partnership with Heng Rui is independent of the contract renewal discussions with Fumisi, indicating that both collaborations can coexist without interference [2]. - Although Yabon has not yet completed the renewal agreement with Fumisi, business operations between the two companies are continuing normally, and Yabon is actively supplying products to Fumisi [2].